site:www.precisionmedicineonline.com

About 2,200 results

Open links in new tab

Any time

precisionmedicineonline.com
https://www.precisionmedicineonline.com
Precision Medicine News and Updates | Precision Medicine Online
Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/breaking-news
Breaking News - Precision Medicine Online
Nov 13, 2024 · The firms agreed to make Caris' whole-exome and whole-transcriptome sequencing tests available through Lumea's BxLink digital pathology software.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/cancer
Precision Oncology News - Precision Medicine Online
6 days ago · The latest news on companion diagnostics and personalized cancer therapy from Precision Medicine Online.
precisionmedicineonline.com
http://www.precisionmedicineonline.com/breaking-news
Breaking News - Precision Medicine Online
Nov 11, 2024 · Patients with MSI-high/dMMR advanced colorectal cancers had a 79 percent lower risk of disease progression or death on Opdivo-Yervoy compared to chemo.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/disease
Disease Research & Diagnostics News | Precision Medicine Online
News and analysis on disease research and diagnostics from Precision Medicine Online.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/molecular-diagnostics
Molecular Diagnostics News | Precision Medicine Online
Nov 11, 2024 · News on lab-developed tests, emerging diagnostic technologies and tests from Precision Medicine Online.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/technology
Genomics Technology, Tools & Methods - Precision Medicine Online
Oct 29, 2024 · The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from Precision Medicine Online.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/precision...
Aptose Launches Phase I/II Study of FLT3 Inhibitor in Newly …
3 days ago · NEW YORK – Aptose Biosciences on Wednesday said it began testing its multi-kinase inhibitor tuspetinib with azacitidine and AbbVie and Genentech's Venclexta (venetoclax) in a Phase I/II trial as a triplet therapy in patients with …
precisionmedicineonline.com
https://www.precisionmedicineonline.com/research
Genomics Research & Discovery | Precision Medicine Online
Oct 8, 2024 · The latest research news in genetics and genomics from Precision Medicine Online.
precisionmedicineonline.com
https://www.precisionmedicineonline.com/topic/precision-oncology
Precision Oncology Precision Oncology News - Precision Medicine …
Oct 7, 2024 · The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Pagination
- 1
- 2
- 3
- 4
- Next